Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection (Q61909454)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection |
clinical trial |
Statements
KIRAL (English)
0 references
Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection: Observational Retrospective Study at 48 Weeks - KIRAL Study (English)
0 references
15 November 2016
0 references
20 April 2017
0 references
467
0 references
18 year
0 references